The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Sodium chloride 0.9% w/v solvent for parenteral use



Fresenius Kabi Deutschland GmbHPA2059/063/006

Main Information

Trade NameSodium chloride 0.9% w/v solvent for parenteral use
Active SubstancesSodium chloride
Dosage FormSolvent for parenteral use
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/063/006

Group Information

ATC CodeB05XA Electrolyte solutions
B05XA03 sodium chloride

Status

License statusAuthorised
Licence Issued28/08/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back